Lianjiang People's hospital
Welcome,         Profile    Billing    Logout  
 36 Trials 
79 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chen, Wei
NCT06467513: To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications

Recruiting
4
102
RoW
Esketamine hydrochloride injection, 0.9% sodium chloride injection
Zhang XIao Mei
Heart Diseases, Heart Valve Diseases
05/25
05/25
NCT05181475: Long-term Efficacy and Safety Study of GV-971

Active, not recruiting
4
800
RoW
Sodium Oligomannate Capsules (GV-971)
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Alzheimer Disease
01/25
06/25
NCT06597201: Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.

Recruiting
4
400
RoW
amino acid (15) peritoneal dialysis solution, glucose peritoneal dialysis solution
Chengdu Qingshan Likang Pharmaceutical Co., Ltd
End Stage Renal Disease (ESRD)
06/25
06/25
NCT05721404: Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis

Recruiting
4
194
RoW
Icodextrin Peritoneal Dialysis Solution, Hypertonic Dextrose solution
First Affiliated Hospital, Sun Yat-Sen University, Baxter Healthcare Corporation
Peritoneal Dialysis
04/25
12/25
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting
4
9000
RoW
Aspirin 100 mg Oral Tablet, Matching Placebo
Guangdong Provincial People's Hospital, The George Institute
CKD (Chronic Kidney Disease) Stage 5D
09/26
12/26
NCT06720233: Efficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal Dialysis

Completed
3
37
RoW
SAL-0951 tablets, SAL-0951 group
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Anemia
10/24
10/24
NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Completed
3
163
RoW
Lotilaner, TP-03, S-Misoxam, Vehicle Control
LianBio LLC
Blepharitis
09/23
04/24
NCT06720025: Study of SAL-0951 Compared to Recombinant Human Erythropoietin in Anemic Patients Receiving Maintenance Hemodialysis

Completed
3
100
RoW
SAL-0951 tablets, SAL-0951 group, rHuEPO injection, rHuEPO group
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Anemia
06/24
06/24
PREPARED-1, NCT06339008: A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis

Recruiting
3
450
Europe, US, RoW
LY3650150, Placebo, Standard therapy for INCS
Eli Lilly and Company
Perennial Allergic Rhinitis (PAR)
10/25
02/27
NCT04370925: Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis

Recruiting
3
688
RoW
Radical colectomy, HIPEC, Systemic chemotherapy
Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Nanfang Hospital of Southern Medical University, Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial People's Hospital, Meizhou People's Hospital, First People's Hospital of Foshan, Shantou Central Hospital, Jiangmen Central Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, ZhuHai Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Hospital, Beijing Cancer Hospital, Peking University People's Hospital, Fudan University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing University Cancer Hospital, First Affiliated Hospital of Chongqing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Wuhan University, Sichuan Provincial People's Hospital, West China Hospital, The People's Hospital of Leshan, People’s Hospital of Deyang City, Hebei Medical University Fourth Hospital, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital Of Southwest Medical University, The Affiliated Hospital of Xuzhou Medical University, People's Hospital of Guangxi, The Third People's Hospital of Chengdu, The Affiliated Tumor Hospital of Guangxi Medical University
Colorectal Cancer
04/24
04/26
TRAILRUNNER-ALZ 3, NCT06653153: A Study of Remternetug (LY3372993) in Early Alzheimer's Disease

Recruiting
3
1200
Europe, Canada, Japan, US, RoW
Remternetug, LY3372993, Placebo
Eli Lilly and Company
Alzheimer's Disease
04/29
10/30
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

Recruiting
3
400
RoW
SJP-0132, Placebo
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd.
Dry Eye
07/25
08/25
MOUNTAINEER-03, NCT05253651 / 2021-002672-40: A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Recruiting
3
400
Europe, Canada, Japan, US, RoW
tucatinib, TUKYSA, ONT-380, ARRY-380, PF-07265792, trastuzumab, Herceptin, bevacizumab, Avastin, cetuximab, Erbitux, oxaliplatin, leucovorin, levoleucovorin, fluorouracil
Seagen, a wholly owned subsidiary of Pfizer, Merck Sharp & Dohme LLC
Colorectal Neoplasms
04/26
07/29
TRAILBLAZER-ALZ 5, NCT05508789: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease

Recruiting
3
1500
Europe, RoW
Donanemab, (LY3002813), Placebo
Eli Lilly and Company
Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders
05/28
07/28
COMBAT-ALS, NCT04057898 / 2019-003549-14: Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS

Recruiting
2/3
230
Canada, US
MN-166, ibudilast, placebo
MediciNova
Amyotrophic Lateral Sclerosis
12/25
12/26
NCT06470191: A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

Recruiting
2/3
216
RoW
B007, Cyclosporin Capsules
Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd
Primary Membranous Nephropathy
12/26
12/26
NCT05811442: Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

Recruiting
2a
60
RoW
50561 high dose, 50561 low dose, Placebo
Beijing Joekai Biotechnology LLC
Alzheimer's Disease
05/24
06/24
NCT06435182: Study of OT202 in Treating Moderate to Severe Dry Eye

Completed
2
213
RoW
OT202 conc 0.5%, Investigational product, OT202 conc 0.1%, Placebo
Ocumension Therapeutics (Shanghai) Co., Ltd
Dry Eye
01/24
01/24
NCT05810961: A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)

Terminated
2
8
RoW
efgartigimod IV, placebo
argenx, Zai Lab Pty. Ltd.
Membranous Nephropathy
08/24
08/24
NCT05810948: A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Lupus Nephritis (ZL-1103-013)

Active, not recruiting
2
73
RoW
efgartigimod IV, Placebo
argenx, Zai Lab (Shanghai) Co., Ltd.
Lupus Nephritis
07/25
09/25
NCT05593575: Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease

Completed
2
305
RoW
SPH3127+SPH3127matching placebo+valsartan matching placebo, SPH3127+valsartan matching placebo, SPH3127 matching placebo+valsartan
Shanghai Pharmaceuticals Holding Co., Ltd
Diabetic Kidney Disease
12/24
12/24
NICRRBTC, NCT06699459: Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC

Not yet recruiting
2
76
RoW
Irinotecan Liposome, Irinotecan Liposome+LV/5-FU, Capecitabine
Sir Run Run Shaw Hospital, Zhejiang Cancer Hospital, RenJi Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Fujian Provincial Hospital, Ningbo No. 1 Hospital, Shaoxing People's Hospital, Southern Medical University, China, First Affiliated Hospital, Sun Yat-Sen University
Biliary Tract Carcinoma
11/26
11/26
NCT06861101: Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults

Completed
2
370
RoW
JT002 Nasal spray, Placebo
Shanghai JunTop Biosciences Co., LTD
Seasonal Allergic Rhinitis
05/25
05/25
NCT06760182: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis

Recruiting
2
168
RoW
TQH2722 injection, TQH2722 Placebo
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Seasonal Allergic Rhinitis
06/25
08/25
NCT06837233: A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis

Active, not recruiting
2
160
RoW
Pumecitinib Nasal Spray 0.3%, Pumecitinib Nasal Spray 0.6%, Placebo (twice daily), Pumecitinib nasal spray 0.6%(twice daily), Placebo
Prime Gene Therapeutics Co., Ltd.
Seasonal Allergic Rhinitis
05/25
05/26
MAGIC, NCT05053802: Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial

Recruiting
2
146
RoW
Microwave ablation plus Camrelizumab, Microwave ablation
Shanghai Pulmonary Hospital, Shanghai, China
Multiple Primary Lung Cancer
09/25
09/27
PALIZADE, NCT05781750: A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis

Suspended
2
279
Europe, US, RoW
zetomipzomib, KZR-616, placebo, matching placebo
Kezar Life Sciences, Inc.
Lupus Nephritis
05/26
07/26
NCT06155084: A Phase I/II Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

Recruiting
1/2
84
RoW
HP518 - Dose Escalation, Part 1 - Dose Escalation, HP518 -Dose Expansion, Part 2 - Dose Expansion Oral tablet(s)
Hinova Pharmaceuticals Inc.
Metastatic Castration-resistant Prostate Cancer
10/25
09/26
NCT06474416: A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

Active, not recruiting
1
16
RoW
BD111 Injection (Investigative New Drug), BD111 Lentivirus-like particles, HSV-1-erasing lentiviral particles, HELP, Triple-drugs therapy of HSV-1 stromal keratitis, Ganciclovir Ophthalmic Gel, Valacyclovir Hydrochloride Tablets, Prednisolone Acetate Ophthalmic Suspension
Shanghai BDgene Co., Ltd.
Herpes Simplex Virus Type I Stromal Keratitis
10/25
03/26
NCT05633459: A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

Recruiting
1
64
Europe, Canada
Multiple ascending doses of QRL-201, Multiple ascending doses of Placebo, QRL-201, Placebo
QurAlis Corporation
Amyotrophic Lateral Sclerosis
08/26
08/26
HOPE, NCT06682507: High Quality Evidence of Guangzhou Lupus Nephritis Cohort ( Cohort)

Recruiting
N/A
5000
RoW
No Intervention: Observational Cohort
First Affiliated Hospital, Sun Yat-Sen University
Lupus Nephritis (LN)
12/50
12/50
POSDOT, NCT02999932: Peripheral Oxygen Saturation (SpO2) Directed Oxygen Therapy

Terminated
N/A
1706
RoW
SpO2 directed oxygen therapy
Wuhan Union Hospital, China, Wu Jieping Medical Foundation
Critical Illness
05/22
05/22
NCT05311462: An Observational Cohort Study to Obese Patients With Weight Cycling

Active, not recruiting
N/A
180
RoW
Peking Union Medical College Hospital
Weight Cycling, Obesity
01/25
12/28
NCT05570435: Efficacy of Milk Product Supplemented With Bioactives in Lowering Post Meal Glucose Response

Completed
N/A
31
RoW
Blood collection
Société des Produits Nestlé (SPN), Peking Union Medical College Hospital
Healthy, PreDiabetes, Adult, Asian
03/23
03/23
NCT05857917: Virtual Reality for for Pain and Anxiety Distraction Strategy on Peritoneal Catheter Insertion

Recruiting
N/A
70
RoW
Virtual Reality
First Affiliated Hospital, Sun Yat-Sen University
Renal Function Disorder
10/23
10/23
NCT05859165: To Evaluate Clinical Efficacy and Safety of Diabetes-Specific Formula (Nutren Diabetes)

Recruiting
N/A
250
RoW
Nutren Diabetes, Fresubin Diabetes
Société des Produits Nestlé (SPN), Nestle Health Science
Diabetes Mellitus
03/25
08/25
ASQ-GYO, NCT06339827: ASk Questions in GYnecologic Oncology

Recruiting
N/A
70
US
Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List
Ira Winer
Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Vulvar Cancer, Vaginal Cancer, Gestational Trophoblastic Disease
05/27
05/28
NCT05651321: Studies on the Impact of Taste-aware Intelligent Analysis of Oral Nutritional Supplements

Recruiting
N/A
108
RoW
Samples materials of basic taste stimuli and enteral nutrition preparations
Peking Union Medical College Hospital
Cancer- and Cancer Treatment-Related Conditions, Stroke
06/24
12/24
WHIP, NCT06545721: Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome

Not yet recruiting
N/A
425
RoW
Adjusting dietary structure + exercise + behavioral intervention
Peking Union Medical College Hospital
Polycystic Ovary Syndrome
08/25
08/26

Active, not recruiting
N/A
11737
US
Tulane University, National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS)
Atherosclerosis, Cardiovascular Diseases, Heart Diseases, Coronary Disease, Hypertension
11/29
11/29
NCT05190848: Correlation of Microbiome and Metabonomics With IgA Nephropathy

Recruiting
N/A
600
RoW
Guangdong Provincial People's Hospital
IgA Nephropathy
12/24
12/25
CAM Cohort, NCT06798077: Chronic Airway Disease and Multimorbidity Cohort

Recruiting
N/A
2000
RoW
China-Japan Friendship Hospital, Second Affiliated Hospital of Xi'an Jiaotong University, First Hospital of China Medical University, Henan Provincial People's Hospital, Second Xiangya Hospital of Central South University, Sichuan University, Southern Medical University, China, Ruijin Hospital, Wuhan Union Hospital, China
Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis
07/28
07/28
NCT06793475: Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease

Recruiting
N/A
20
RoW
anti-BCMA/GPRC5D bispecific CAR-T, Apornemin, Carfilzomib, Thalidomide, Dexamethasone
Institute of Hematology & Blood Diseases Hospital, China
Extramedullary Multiple Myeloma
06/26
12/26
NCT06962436: RAB Versus Ultrathin Bronchoscopy With VBN in the Diagnosis of PPNs

Not yet recruiting
N/A
184
RoW
Robotic bronchoscopy system, Ultrathin bronchoscope combined with virtual bronchoscopic navigation
Shanghai Chest Hospital
Peripheral Pulmonary Nodules
11/26
12/26
NCT07034807: YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2

Not yet recruiting
N/A
228
RoW
the traditional Chinese medicine prescription ' Shenzhuo Decoction ', Chinese medicine, basic treatment, control group
Liu Hongfang, Guang'anmen Hospital,China Academy of Chinese Medical Sciencescancel, First Affiliated Hospital, Sun Yat-Sen University, Tianjin Medical University Chu Hsien-I Memorial Hospital, The Affiliated Hospital to ChangChun University of Chinese Medicinecancel, EFONG PHARMRCEUTICRL
Diabetic Kidney Disease (DKD)
07/28
07/28
NCT07032116: YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1

Not yet recruiting
N/A
4472
RoW
Liu Hongfang, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, First Affiliated Hospital, Sun Yat-Sen University, Tianjin Medical University Chu Hsien-I Memorial Hospital, Changchun University of Chinese Medicine, EFONG PHARMRCEUTICRL, Xinxiang Central Hospital of Henan province, Xiamen Hospital of Traditional Chinese Medicine, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Beijing Tiantan Hospital, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Hubei Zhongshan Hospital Affiliated to Wuhan University
Diabetic Kidney Disease (DKD)
07/28
07/28
NCT04212494: Thrombus Aspiration in STEMI Patients With High Thrombus Burden

Recruiting
N/A
3838
RoW
Thrombus aspiration, PCI Alone
Guangdong Provincial People's Hospital, Zhongshan People's Hospital, Guangdong, China, Kaiping Central Hospital, The Second Affiliated Hospital of Shantou University Medical College, The Third Xiangya Hospital of Central South University, Sihui City People's Hospital, Shenzhen Baoan District Shiyan People's Hospital, People's Hospital of Nanxiong County, Yuebei People's Hospital, Weifang Medical University, Wuzhou Gongren Hospital, Dafeng Hospital of Chaoyang District in Shantou City, Shenzhen Baoan People's Hospital, Dongguan People's Hospital, Yangchun People's Hospital, Taishan People's Hospital, The Second People's Hospital of Foshan, Guangzhou Hospital of integrated Traditional and West Medicine, Guangning People's Hospital, Foshan Sanshui District People's Hospital, Qingyuan People's Hospital, Luhe County People's Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, The Fourth People's Hospital of Chenzhou, People's Hospital of Dapu County, Shenzhen People's Hospital, Heyuan people's Hospital, Huaiji People's Hospital, People's Hospital of Yingde City, Qingyuan Hospital of Traditional Chinese Medicine Affiliated To Guangzhou University of Traditional Chinese Medicine, Zhongshan Hospital Of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Lianzhou People's Hospital, Lianping Xian Ren Ming Yi Yuan, Guangxi Zhuang Autonomous Region Nationalities Hospital, Liuzhou Municipal Liutie Central Hospital, Chen Zhou 3RD People's Hospital, Longgang District Central Hospital of Shenzhen, The Affiliated Shunde Hospital of Jinan University, Shenzhen Longhua District Central Hospital, Shantou Central Hospital, Tongxiang First People's Hospital, Bobai County People's Hospital, Guangxi, Meizhou Traditional Chinese Medicine Hospital, The Third Affiliated Hospital of Sun Yat-Sen University, Yuedong Hospital, Shenzhen Third People's Hospital, Yangjiang People's Hospital, Jiangmen Central Hospital, Eighth Affiliated Hospital, Sun Yat-sen University, The First People's Hospital of Kashgar Erea, First People's Hospital of Foshan, Zhaoqing Gaoyao People's Hospital, People's Hospital of Nanhai District, Foshan, The Second Affiliated Hospital of Dalian Medical University, Nanning Second People's Hospital, The Second People's Hospital of Nanhai District of Foshan, Shangyou People's Hospital
ST-segment Elevation Myocardial Infarction (STEMI)
08/25
02/26
NCT05754866: Transbronchial Lung Cryobiopsy in Undiagnosed Acute Respiratory Failure

Recruiting
N/A
100
RoW
Transbronchial lung cryobiopsy, Transbronchial lung biopsy
China-Japan Friendship Hospital
Acute Respiratory Failure, Acute Respiratory Distress Syndrome
11/25
11/25
NCT05188885: A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases

Recruiting
N/A
90000
RoW
Guangdong Provincial People's Hospital
Chronic Kidney Disease
12/26
12/28
NCT04088071: Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation

Recruiting
N/A
15000
Canada, US
Catheter ablation
Heart Rhythm Clinical and Research Solutions, LLC, Biosense Webster, Inc.
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
12/27
12/27
wang, hua
NCT06476210: The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)

Recruiting
4
45
RoW
BDL regimen
Beijing Chest Hospital, Public Health Clinical Medical Center of Chengdu, Wuhan Institute for Tuberculosis Control, Changsha Central Hospital, Anhui Chest Hospital, Hunan Chest Hospital, Shandong Public Health Clinical Center
Pulmonary Tuberculosis
06/25
06/26
PROSPECT, NCT05306223: A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China

Recruiting
4
212
RoW
Bedaquiline, SIRTURO, Levofloxacin, Linezolid, Cycloserine, Clofazimine, Pyrazinamide, Protionamide
Beijing Chest Hospital
Tuberculosis, Multidrug-Resistant
08/25
08/25
NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Completed
3
163
RoW
Lotilaner, TP-03, S-Misoxam, Vehicle Control
LianBio LLC
Blepharitis
09/23
04/24
NCT06280716: A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis

Recruiting
3
430
RoW
Placebo, Lebrikizumab, LY3650150, Topical Corticosteroid
Eli Lilly and Company
Atopic Dermatitis
12/25
11/26
INSPIRE-BDLL, NCT06649721: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BDLL Chinese Cohort

Recruiting
3
120
RoW
bedaquiline, BDQ, B, delamanid, DLM, D, linezolid, LZD, L, Levofloxacin, LFX, Clofazimine, CFZ, C
Huashan Hospital, Beijing Chest Hospital
Drug-resistant Tuberculosis, Pulmonary Tuberculosis, Rifampin-resistant Tuberculosis
02/27
06/27
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

Recruiting
3
400
RoW
SJP-0132, Placebo
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd.
Dry Eye
07/25
08/25
NCT05899179: Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above

Recruiting
3
780
RoW
Recombinant Mycobacterium Tuberculosis Fusion Protein, EC, Purified Protein Derivative of Tuberculin, TB-PPD
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Shenzhen Third People's Hospital, Wuhan Institute for Tuberculosis Control
Latent Tuberculosis Infection
06/25
10/25
MOUNTAINEER-03, NCT05253651 / 2021-002672-40: A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Recruiting
3
400
Europe, Canada, Japan, US, RoW
tucatinib, TUKYSA, ONT-380, ARRY-380, PF-07265792, trastuzumab, Herceptin, bevacizumab, Avastin, cetuximab, Erbitux, oxaliplatin, leucovorin, levoleucovorin, fluorouracil
Seagen, a wholly owned subsidiary of Pfizer, Merck Sharp & Dohme LLC
Colorectal Neoplasms
04/26
07/29
INSPIRE-CODA, NCT06081361: Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline Cohort

Active, not recruiting
3
186
RoW
Bedaquiline, BDQ, Delamanid, DLM, Contezolid, CZD, Levofloxacin, LFX, Moxifloxacin, MFX, Clofazimine, CFZ, Linezolid, LZD, Cycloserine, CS, Prothionamide, Pto, Pyrazinamide, PZA, Para-Aminosalicylic Acid, PAS, Ethambutol, EMB
Beijing Chest Hospital, National Medical Center for Infectious Diseases
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
10/26
12/26
B2018-053, NCT06406556: Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL

Recruiting
2
90
RoW
Pegaspargase combined with concurrent radiotherapy.
Sun Yat-sen University
Extranodal NK/T-cell Lymphoma
03/26
03/26
NCT04254640: Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML

Not yet recruiting
2
34
RoW
Cladribine Injection, 2-chlorodeoxyadenosine, Aclarubicin, aclarubicin hydrochloride, G-CSF, Granulocyte Colony-Stimulating Factor, cytarabine, cytarabine hydrochloride
Sun Yat-sen University
Acute Myeloid Leukemia, Elderly Patients, Newly Diagnosed
06/23
12/23
NCT04892498: Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)

Recruiting
2
66
RoW
Hypofractionated radiotherapy, PD-1 inhibitor, GM-CSF, IL-2
Second Affiliated Hospital of Soochow University
Advanced Refractory Solid Tumors
08/23
08/24
NCT02705508: PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma

Recruiting
2
35
RoW
Gemcitabine, Gemzar, etoposide, Etoposide phosphate, Pegaspargase, Oncaspar, involved-field radiotherapy, IFRT
Sun Yat-sen University, China Food and Drug Administration
Treatment Refusal
12/23
12/23
SPENT, NCT04676789: Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL

Not yet recruiting
2
30
RoW
Pegaspargase, P-ASP, Anti-PD-1 monoclonal antibody, sintilimab, Definitive intensity-modulated radiotherapy (IMRT), IMRT
Sun Yat-sen University
Extranodal NK/T-cell Lymphoma, Nasal Type
09/24
12/24
NCT05564897: Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer

Recruiting
2
25
RoW
H101, Camrelizumab
Zhejiang Cancer Hospital
Bladder Cancer
09/24
12/24
TQB3702-II-02, NCT06566586: A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma

Recruiting
2
80
RoW
TQB3702 tablets+Chemotherapy regimen
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
B-cell Lymphoma
03/26
12/27
NCT02396043: Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

Recruiting
2
50
RoW
induction phase1, Vincristine,Pirarubicin,Prednisone,Pegaspargase, induction phase2, Cyclophosphamide,Cytarabine,Mercaptopurine, protocol M, Methotrexate,Mercaptopurine, maintenance therapy, 6-mercaptopurine,Methotrexate, reinduction phase1, reinduction phase2, Intrathecal (IT), methotrexate ,cytarabine and dexamethasone
Sun Yat-sen University
Lymphoma, Lymphoblastic
03/25
03/25
NCT03641456: VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma

Recruiting
2
50
RoW
bortezomib, Velcade, Lenalidomide, Revlimid, Dexamethasone, Dexamethasone Acetate
Sun Yat-sen University
Myeloma, Newly Diagnosed, High Risk
12/25
12/25
TranStar102, NCT04495296: A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors

Recruiting
1/2
320
RoW
TST001, Oxaliplatin, Capecitabine, Paclitaxel, Gemcitabine, Cisplatin, Nivolumab
Suzhou Transcenta Therapeutics Co., Ltd., Bristol-Myers Squibb
Advanced Cancer
02/25
05/25
NCT05824169: Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients

Recruiting
1/2
18
RoW
GC101
GeneCradle Inc
Spinal Muscular Atrophy
12/26
12/26
SHR-A1811-208, NCT06015048: A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.

Recruiting
1/2
364
RoW
SHR-A1811 combined with Pyrotinib., SHR-A1811 combined with other antitumor therapies
Jiangsu HengRui Medicine Co., Ltd.
HER2-expressing Advanced Solid Tumors
11/26
12/26
NCT06525272: A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of OsrhCT in Patients With Pleurisy

Not yet recruiting
1
72
RoW
Recombinant Human Chymotrypsin(OsrhCT), Freeze-dried Powder of Recombinant Human Chymotrypsin(OsrhCT), Placebo for Recombinant Human Chymotrypsin(OsrhCT), Freeze-dried Powder of Placebo for Recombinant Human Chymotrypsin(OsrhCT)
Healthgen Biotechnology Corp.
Pleurisy
07/25
12/25
NCT02698839: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Active, not recruiting
N/A
539
RoW
BuMA Supreme, BuMA™
Sino Medical Sciences Technology Inc.
Coronary Artery Disease
03/18
12/25
NCT04554511: Prognostic Nomogram of Extranodal NK/T-cell Lymphoma

Recruiting
N/A
1000
RoW
Sun Yat-sen University
Extranodal NK/T-cell Lymphoma
01/24
01/24
NCT03059043: Safety and Efficacy Study of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation

Recruiting
N/A
60
RoW
viscoelastic-free implantation system, standard viscoelastic-assisted Implantation system
Wenzhou Medical University
Myopia
06/26
06/26
CAA+PGP#PWB, NCT06841133: Chinese Art Activities or Combined With Peer Group Participation on Psychological Well Being

Not yet recruiting
N/A
90
RoW
Chinese Art Activities, Chinese Art Activities combined with Peer Group Participation (PGP)
Prince of Songkla University
Aging
07/25
08/25
Jiang, Zongpei
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting
4
9000
RoW
Aspirin 100 mg Oral Tablet, Matching Placebo
Guangdong Provincial People's Hospital, The George Institute
CKD (Chronic Kidney Disease) Stage 5D
09/26
12/26
Xie, Jianteng
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting
4
9000
RoW
Aspirin 100 mg Oral Tablet, Matching Placebo
Guangdong Provincial People's Hospital, The George Institute
CKD (Chronic Kidney Disease) Stage 5D
09/26
12/26
Wen, Chaohui
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting
4
9000
RoW
Aspirin 100 mg Oral Tablet, Matching Placebo
Guangdong Provincial People's Hospital, The George Institute
CKD (Chronic Kidney Disease) Stage 5D
09/26
12/26
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chen, Wei
NCT06467513: To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications

Recruiting
4
102
RoW
Esketamine hydrochloride injection, 0.9% sodium chloride injection
Zhang XIao Mei
Heart Diseases, Heart Valve Diseases
05/25
05/25
NCT05181475: Long-term Efficacy and Safety Study of GV-971

Active, not recruiting
4
800
RoW
Sodium Oligomannate Capsules (GV-971)
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Alzheimer Disease
01/25
06/25
NCT06597201: Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition.

Recruiting
4
400
RoW
amino acid (15) peritoneal dialysis solution, glucose peritoneal dialysis solution
Chengdu Qingshan Likang Pharmaceutical Co., Ltd
End Stage Renal Disease (ESRD)
06/25
06/25
NCT05721404: Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis

Recruiting
4
194
RoW
Icodextrin Peritoneal Dialysis Solution, Hypertonic Dextrose solution
First Affiliated Hospital, Sun Yat-Sen University, Baxter Healthcare Corporation
Peritoneal Dialysis
04/25
12/25
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting
4
9000
RoW
Aspirin 100 mg Oral Tablet, Matching Placebo
Guangdong Provincial People's Hospital, The George Institute
CKD (Chronic Kidney Disease) Stage 5D
09/26
12/26
NCT06720233: Efficacy and Safety Study of SAL-0951 in the Treatment of Renal Anemia in Patients Receiving Peritoneal Dialysis

Completed
3
37
RoW
SAL-0951 tablets, SAL-0951 group
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Anemia
10/24
10/24
NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Completed
3
163
RoW
Lotilaner, TP-03, S-Misoxam, Vehicle Control
LianBio LLC
Blepharitis
09/23
04/24
NCT06720025: Study of SAL-0951 Compared to Recombinant Human Erythropoietin in Anemic Patients Receiving Maintenance Hemodialysis

Completed
3
100
RoW
SAL-0951 tablets, SAL-0951 group, rHuEPO injection, rHuEPO group
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Anemia
06/24
06/24
PREPARED-1, NCT06339008: A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis

Recruiting
3
450
Europe, US, RoW
LY3650150, Placebo, Standard therapy for INCS
Eli Lilly and Company
Perennial Allergic Rhinitis (PAR)
10/25
02/27
NCT04370925: Efficacy of HIPEC in Patients With Colorectal Cancer at High Risk of Peritoneal Carcinomatosis

Recruiting
3
688
RoW
Radical colectomy, HIPEC, Systemic chemotherapy
Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Nanfang Hospital of Southern Medical University, Sun Yat-sen University, Sixth Affiliated Hospital, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangdong Provincial People's Hospital, Meizhou People's Hospital, First People's Hospital of Foshan, Shantou Central Hospital, Jiangmen Central Hospital, Shenzhen Second People's Hospital, Zhongshan People's Hospital, Guangdong, China, ZhuHai Hospital, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing Hospital, Beijing Cancer Hospital, Peking University People's Hospital, Fudan University, The Second Affiliated Hospital of Chongqing Medical University, Chongqing University Cancer Hospital, First Affiliated Hospital of Chongqing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Wuhan University, Sichuan Provincial People's Hospital, West China Hospital, The People's Hospital of Leshan, People’s Hospital of Deyang City, Hebei Medical University Fourth Hospital, The First Affiliated Hospital of Nanchang University, The Affiliated Hospital Of Southwest Medical University, The Affiliated Hospital of Xuzhou Medical University, People's Hospital of Guangxi, The Third People's Hospital of Chengdu, The Affiliated Tumor Hospital of Guangxi Medical University
Colorectal Cancer
04/24
04/26
TRAILRUNNER-ALZ 3, NCT06653153: A Study of Remternetug (LY3372993) in Early Alzheimer's Disease

Recruiting
3
1200
Europe, Canada, Japan, US, RoW
Remternetug, LY3372993, Placebo
Eli Lilly and Company
Alzheimer's Disease
04/29
10/30
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

Recruiting
3
400
RoW
SJP-0132, Placebo
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd.
Dry Eye
07/25
08/25
MOUNTAINEER-03, NCT05253651 / 2021-002672-40: A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Recruiting
3
400
Europe, Canada, Japan, US, RoW
tucatinib, TUKYSA, ONT-380, ARRY-380, PF-07265792, trastuzumab, Herceptin, bevacizumab, Avastin, cetuximab, Erbitux, oxaliplatin, leucovorin, levoleucovorin, fluorouracil
Seagen, a wholly owned subsidiary of Pfizer, Merck Sharp & Dohme LLC
Colorectal Neoplasms
04/26
07/29
TRAILBLAZER-ALZ 5, NCT05508789: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease

Recruiting
3
1500
Europe, RoW
Donanemab, (LY3002813), Placebo
Eli Lilly and Company
Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Tauopathies, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders
05/28
07/28
COMBAT-ALS, NCT04057898 / 2019-003549-14: Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS

Recruiting
2/3
230
Canada, US
MN-166, ibudilast, placebo
MediciNova
Amyotrophic Lateral Sclerosis
12/25
12/26
NCT06470191: A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

Recruiting
2/3
216
RoW
B007, Cyclosporin Capsules
Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd
Primary Membranous Nephropathy
12/26
12/26
NCT05811442: Study of 50561 in Patients With Mild or Moderate Alzheimer's Disease

Recruiting
2a
60
RoW
50561 high dose, 50561 low dose, Placebo
Beijing Joekai Biotechnology LLC
Alzheimer's Disease
05/24
06/24
NCT06435182: Study of OT202 in Treating Moderate to Severe Dry Eye

Completed
2
213
RoW
OT202 conc 0.5%, Investigational product, OT202 conc 0.1%, Placebo
Ocumension Therapeutics (Shanghai) Co., Ltd
Dry Eye
01/24
01/24
NCT05810961: A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)

Terminated
2
8
RoW
efgartigimod IV, placebo
argenx, Zai Lab Pty. Ltd.
Membranous Nephropathy
08/24
08/24
NCT05810948: A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Lupus Nephritis (ZL-1103-013)

Active, not recruiting
2
73
RoW
efgartigimod IV, Placebo
argenx, Zai Lab (Shanghai) Co., Ltd.
Lupus Nephritis
07/25
09/25
NCT05593575: Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease

Completed
2
305
RoW
SPH3127+SPH3127matching placebo+valsartan matching placebo, SPH3127+valsartan matching placebo, SPH3127 matching placebo+valsartan
Shanghai Pharmaceuticals Holding Co., Ltd
Diabetic Kidney Disease
12/24
12/24
NICRRBTC, NCT06699459: Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC

Not yet recruiting
2
76
RoW
Irinotecan Liposome, Irinotecan Liposome+LV/5-FU, Capecitabine
Sir Run Run Shaw Hospital, Zhejiang Cancer Hospital, RenJi Hospital, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Fujian Provincial Hospital, Ningbo No. 1 Hospital, Shaoxing People's Hospital, Southern Medical University, China, First Affiliated Hospital, Sun Yat-Sen University
Biliary Tract Carcinoma
11/26
11/26
NCT06861101: Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults

Completed
2
370
RoW
JT002 Nasal spray, Placebo
Shanghai JunTop Biosciences Co., LTD
Seasonal Allergic Rhinitis
05/25
05/25
NCT06760182: Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis

Recruiting
2
168
RoW
TQH2722 injection, TQH2722 Placebo
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Seasonal Allergic Rhinitis
06/25
08/25
NCT06837233: A Study to Assess the Efficacy and Safety of PG-011 Nasal Spray in Adults With Moderate to Severe Seasonal Allergic Rhinitis

Active, not recruiting
2
160
RoW
Pumecitinib Nasal Spray 0.3%, Pumecitinib Nasal Spray 0.6%, Placebo (twice daily), Pumecitinib nasal spray 0.6%(twice daily), Placebo
Prime Gene Therapeutics Co., Ltd.
Seasonal Allergic Rhinitis
05/25
05/26
MAGIC, NCT05053802: Efficiency and Safety of Microwave Ablation Plus Immune Checkpoint Inhibitor for Patients With Multiple Primary Lung Cancer: A Open, Multi-center, Phase II Clinical Trial

Recruiting
2
146
RoW
Microwave ablation plus Camrelizumab, Microwave ablation
Shanghai Pulmonary Hospital, Shanghai, China
Multiple Primary Lung Cancer
09/25
09/27
PALIZADE, NCT05781750: A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis

Suspended
2
279
Europe, US, RoW
zetomipzomib, KZR-616, placebo, matching placebo
Kezar Life Sciences, Inc.
Lupus Nephritis
05/26
07/26
NCT06155084: A Phase I/II Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients

Recruiting
1/2
84
RoW
HP518 - Dose Escalation, Part 1 - Dose Escalation, HP518 -Dose Expansion, Part 2 - Dose Expansion Oral tablet(s)
Hinova Pharmaceuticals Inc.
Metastatic Castration-resistant Prostate Cancer
10/25
09/26
NCT06474416: A Study of the Safety, Tolerability and Prelinminary Efficacy of BD111 in Herpes Simplex Virus Type I Stromal Keratitis

Active, not recruiting
1
16
RoW
BD111 Injection (Investigative New Drug), BD111 Lentivirus-like particles, HSV-1-erasing lentiviral particles, HELP, Triple-drugs therapy of HSV-1 stromal keratitis, Ganciclovir Ophthalmic Gel, Valacyclovir Hydrochloride Tablets, Prednisolone Acetate Ophthalmic Suspension
Shanghai BDgene Co., Ltd.
Herpes Simplex Virus Type I Stromal Keratitis
10/25
03/26
NCT05633459: A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

Recruiting
1
64
Europe, Canada
Multiple ascending doses of QRL-201, Multiple ascending doses of Placebo, QRL-201, Placebo
QurAlis Corporation
Amyotrophic Lateral Sclerosis
08/26
08/26
HOPE, NCT06682507: High Quality Evidence of Guangzhou Lupus Nephritis Cohort ( Cohort)

Recruiting
N/A
5000
RoW
No Intervention: Observational Cohort
First Affiliated Hospital, Sun Yat-Sen University
Lupus Nephritis (LN)
12/50
12/50
POSDOT, NCT02999932: Peripheral Oxygen Saturation (SpO2) Directed Oxygen Therapy

Terminated
N/A
1706
RoW
SpO2 directed oxygen therapy
Wuhan Union Hospital, China, Wu Jieping Medical Foundation
Critical Illness
05/22
05/22
NCT05311462: An Observational Cohort Study to Obese Patients With Weight Cycling

Active, not recruiting
N/A
180
RoW
Peking Union Medical College Hospital
Weight Cycling, Obesity
01/25
12/28
NCT05570435: Efficacy of Milk Product Supplemented With Bioactives in Lowering Post Meal Glucose Response

Completed
N/A
31
RoW
Blood collection
Société des Produits Nestlé (SPN), Peking Union Medical College Hospital
Healthy, PreDiabetes, Adult, Asian
03/23
03/23
NCT05857917: Virtual Reality for for Pain and Anxiety Distraction Strategy on Peritoneal Catheter Insertion

Recruiting
N/A
70
RoW
Virtual Reality
First Affiliated Hospital, Sun Yat-Sen University
Renal Function Disorder
10/23
10/23
NCT05859165: To Evaluate Clinical Efficacy and Safety of Diabetes-Specific Formula (Nutren Diabetes)

Recruiting
N/A
250
RoW
Nutren Diabetes, Fresubin Diabetes
Société des Produits Nestlé (SPN), Nestle Health Science
Diabetes Mellitus
03/25
08/25
ASQ-GYO, NCT06339827: ASk Questions in GYnecologic Oncology

Recruiting
N/A
70
US
Administration of the ASk Questions in GYnecologic Oncology (ASQ-GYO) Question Prompt List
Ira Winer
Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Vulvar Cancer, Vaginal Cancer, Gestational Trophoblastic Disease
05/27
05/28
NCT05651321: Studies on the Impact of Taste-aware Intelligent Analysis of Oral Nutritional Supplements

Recruiting
N/A
108
RoW
Samples materials of basic taste stimuli and enteral nutrition preparations
Peking Union Medical College Hospital
Cancer- and Cancer Treatment-Related Conditions, Stroke
06/24
12/24
WHIP, NCT06545721: Weight Cycling on Hyperandrogenemia and Insulin Resistance in Polycystic Ovary Syndrome

Not yet recruiting
N/A
425
RoW
Adjusting dietary structure + exercise + behavioral intervention
Peking Union Medical College Hospital
Polycystic Ovary Syndrome
08/25
08/26

Active, not recruiting
N/A
11737
US
Tulane University, National Heart, Lung, and Blood Institute (NHLBI), National Institute on Aging (NIA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute of Environmental Health Sciences (NIEHS)
Atherosclerosis, Cardiovascular Diseases, Heart Diseases, Coronary Disease, Hypertension
11/29
11/29
NCT05190848: Correlation of Microbiome and Metabonomics With IgA Nephropathy

Recruiting
N/A
600
RoW
Guangdong Provincial People's Hospital
IgA Nephropathy
12/24
12/25
CAM Cohort, NCT06798077: Chronic Airway Disease and Multimorbidity Cohort

Recruiting
N/A
2000
RoW
China-Japan Friendship Hospital, Second Affiliated Hospital of Xi'an Jiaotong University, First Hospital of China Medical University, Henan Provincial People's Hospital, Second Xiangya Hospital of Central South University, Sichuan University, Southern Medical University, China, Ruijin Hospital, Wuhan Union Hospital, China
Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchiectasis
07/28
07/28
NCT06793475: Aponermin-Based Bridging Therapy Prior to CAR-T Infusion in Relapsed/Refractory Multiple Myeloma Patients With Extramedullary Disease

Recruiting
N/A
20
RoW
anti-BCMA/GPRC5D bispecific CAR-T, Apornemin, Carfilzomib, Thalidomide, Dexamethasone
Institute of Hematology & Blood Diseases Hospital, China
Extramedullary Multiple Myeloma
06/26
12/26
NCT06962436: RAB Versus Ultrathin Bronchoscopy With VBN in the Diagnosis of PPNs

Not yet recruiting
N/A
184
RoW
Robotic bronchoscopy system, Ultrathin bronchoscope combined with virtual bronchoscopic navigation
Shanghai Chest Hospital
Peripheral Pulmonary Nodules
11/26
12/26
NCT07034807: YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2

Not yet recruiting
N/A
228
RoW
the traditional Chinese medicine prescription ' Shenzhuo Decoction ', Chinese medicine, basic treatment, control group
Liu Hongfang, Guang'anmen Hospital,China Academy of Chinese Medical Sciencescancel, First Affiliated Hospital, Sun Yat-Sen University, Tianjin Medical University Chu Hsien-I Memorial Hospital, The Affiliated Hospital to ChangChun University of Chinese Medicinecancel, EFONG PHARMRCEUTICRL
Diabetic Kidney Disease (DKD)
07/28
07/28
NCT07032116: YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1

Not yet recruiting
N/A
4472
RoW
Liu Hongfang, Guang'anmen Hospital of China Academy of Chinese Medical Sciences, First Affiliated Hospital, Sun Yat-Sen University, Tianjin Medical University Chu Hsien-I Memorial Hospital, Changchun University of Chinese Medicine, EFONG PHARMRCEUTICRL, Xinxiang Central Hospital of Henan province, Xiamen Hospital of Traditional Chinese Medicine, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Beijing Tiantan Hospital, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, Hubei Zhongshan Hospital Affiliated to Wuhan University
Diabetic Kidney Disease (DKD)
07/28
07/28
NCT04212494: Thrombus Aspiration in STEMI Patients With High Thrombus Burden

Recruiting
N/A
3838
RoW
Thrombus aspiration, PCI Alone
Guangdong Provincial People's Hospital, Zhongshan People's Hospital, Guangdong, China, Kaiping Central Hospital, The Second Affiliated Hospital of Shantou University Medical College, The Third Xiangya Hospital of Central South University, Sihui City People's Hospital, Shenzhen Baoan District Shiyan People's Hospital, People's Hospital of Nanxiong County, Yuebei People's Hospital, Weifang Medical University, Wuzhou Gongren Hospital, Dafeng Hospital of Chaoyang District in Shantou City, Shenzhen Baoan People's Hospital, Dongguan People's Hospital, Yangchun People's Hospital, Taishan People's Hospital, The Second People's Hospital of Foshan, Guangzhou Hospital of integrated Traditional and West Medicine, Guangning People's Hospital, Foshan Sanshui District People's Hospital, Qingyuan People's Hospital, Luhe County People's Hospital, People's Hospital of Xinjiang Uygur Autonomous Region, The Fourth People's Hospital of Chenzhou, People's Hospital of Dapu County, Shenzhen People's Hospital, Heyuan people's Hospital, Huaiji People's Hospital, People's Hospital of Yingde City, Qingyuan Hospital of Traditional Chinese Medicine Affiliated To Guangzhou University of Traditional Chinese Medicine, Zhongshan Hospital Of Traditional Chinese Medicine, The Third Affiliated Hospital of Guangzhou Medical University, Lianzhou People's Hospital, Lianping Xian Ren Ming Yi Yuan, Guangxi Zhuang Autonomous Region Nationalities Hospital, Liuzhou Municipal Liutie Central Hospital, Chen Zhou 3RD People's Hospital, Longgang District Central Hospital of Shenzhen, The Affiliated Shunde Hospital of Jinan University, Shenzhen Longhua District Central Hospital, Shantou Central Hospital, Tongxiang First People's Hospital, Bobai County People's Hospital, Guangxi, Meizhou Traditional Chinese Medicine Hospital, The Third Affiliated Hospital of Sun Yat-Sen University, Yuedong Hospital, Shenzhen Third People's Hospital, Yangjiang People's Hospital, Jiangmen Central Hospital, Eighth Affiliated Hospital, Sun Yat-sen University, The First People's Hospital of Kashgar Erea, First People's Hospital of Foshan, Zhaoqing Gaoyao People's Hospital, People's Hospital of Nanhai District, Foshan, The Second Affiliated Hospital of Dalian Medical University, Nanning Second People's Hospital, The Second People's Hospital of Nanhai District of Foshan, Shangyou People's Hospital
ST-segment Elevation Myocardial Infarction (STEMI)
08/25
02/26
NCT05754866: Transbronchial Lung Cryobiopsy in Undiagnosed Acute Respiratory Failure

Recruiting
N/A
100
RoW
Transbronchial lung cryobiopsy, Transbronchial lung biopsy
China-Japan Friendship Hospital
Acute Respiratory Failure, Acute Respiratory Distress Syndrome
11/25
11/25
NCT05188885: A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases

Recruiting
N/A
90000
RoW
Guangdong Provincial People's Hospital
Chronic Kidney Disease
12/26
12/28
NCT04088071: Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation

Recruiting
N/A
15000
Canada, US
Catheter ablation
Heart Rhythm Clinical and Research Solutions, LLC, Biosense Webster, Inc.
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
12/27
12/27
wang, hua
NCT06476210: The Safety and Efficacy of BDL(Bedaquiline Plus Delamanid Plus Linezolid) Regimen in Subjects With Pulmonary Infection of Multi-drug Resistant Tuberculosis (MDR-TB) or Rifampicin-Resistant Tuberculosis (RR-TB)

Recruiting
4
45
RoW
BDL regimen
Beijing Chest Hospital, Public Health Clinical Medical Center of Chengdu, Wuhan Institute for Tuberculosis Control, Changsha Central Hospital, Anhui Chest Hospital, Hunan Chest Hospital, Shandong Public Health Clinical Center
Pulmonary Tuberculosis
06/25
06/26
PROSPECT, NCT05306223: A Study of an Oral Short-course Regimen Including Bedaquiline for the Treatment of Participants With Multidrug-resistant Tuberculosis in China

Recruiting
4
212
RoW
Bedaquiline, SIRTURO, Levofloxacin, Linezolid, Cycloserine, Clofazimine, Pyrazinamide, Protionamide
Beijing Chest Hospital
Tuberculosis, Multidrug-Resistant
08/25
08/25
NCT05629390: Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study

Completed
3
163
RoW
Lotilaner, TP-03, S-Misoxam, Vehicle Control
LianBio LLC
Blepharitis
09/23
04/24
NCT06280716: A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis

Recruiting
3
430
RoW
Placebo, Lebrikizumab, LY3650150, Topical Corticosteroid
Eli Lilly and Company
Atopic Dermatitis
12/25
11/26
INSPIRE-BDLL, NCT06649721: Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis:BDLL Chinese Cohort

Recruiting
3
120
RoW
bedaquiline, BDQ, B, delamanid, DLM, D, linezolid, LZD, L, Levofloxacin, LFX, Clofazimine, CFZ, C
Huashan Hospital, Beijing Chest Hospital
Drug-resistant Tuberculosis, Pulmonary Tuberculosis, Rifampin-resistant Tuberculosis
02/27
06/27
NCT06717152: Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease

Recruiting
3
400
RoW
SJP-0132, Placebo
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd., Senju Pharmaceutical Co., Ltd.
Dry Eye
07/25
08/25
NCT05899179: Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above

Recruiting
3
780
RoW
Recombinant Mycobacterium Tuberculosis Fusion Protein, EC, Purified Protein Derivative of Tuberculin, TB-PPD
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Shenzhen Third People's Hospital, Wuhan Institute for Tuberculosis Control
Latent Tuberculosis Infection
06/25
10/25
MOUNTAINEER-03, NCT05253651 / 2021-002672-40: A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

Recruiting
3
400
Europe, Canada, Japan, US, RoW
tucatinib, TUKYSA, ONT-380, ARRY-380, PF-07265792, trastuzumab, Herceptin, bevacizumab, Avastin, cetuximab, Erbitux, oxaliplatin, leucovorin, levoleucovorin, fluorouracil
Seagen, a wholly owned subsidiary of Pfizer, Merck Sharp & Dohme LLC
Colorectal Neoplasms
04/26
07/29
INSPIRE-CODA, NCT06081361: Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis:Contezolid, Delamanid and Bedaquiline Cohort

Active, not recruiting
3
186
RoW
Bedaquiline, BDQ, Delamanid, DLM, Contezolid, CZD, Levofloxacin, LFX, Moxifloxacin, MFX, Clofazimine, CFZ, Linezolid, LZD, Cycloserine, CS, Prothionamide, Pto, Pyrazinamide, PZA, Para-Aminosalicylic Acid, PAS, Ethambutol, EMB
Beijing Chest Hospital, National Medical Center for Infectious Diseases
Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
10/26
12/26
B2018-053, NCT06406556: Safety & Efficacy of Peg-ASP-based CCRT in Early Stage ENKTL

Recruiting
2
90
RoW
Pegaspargase combined with concurrent radiotherapy.
Sun Yat-sen University
Extranodal NK/T-cell Lymphoma
03/26
03/26
NCT04254640: Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML

Not yet recruiting
2
34
RoW
Cladribine Injection, 2-chlorodeoxyadenosine, Aclarubicin, aclarubicin hydrochloride, G-CSF, Granulocyte Colony-Stimulating Factor, cytarabine, cytarabine hydrochloride
Sun Yat-sen University
Acute Myeloid Leukemia, Elderly Patients, Newly Diagnosed
06/23
12/23
NCT04892498: Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)

Recruiting
2
66
RoW
Hypofractionated radiotherapy, PD-1 inhibitor, GM-CSF, IL-2
Second Affiliated Hospital of Soochow University
Advanced Refractory Solid Tumors
08/23
08/24
NCT02705508: PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma

Recruiting
2
35
RoW
Gemcitabine, Gemzar, etoposide, Etoposide phosphate, Pegaspargase, Oncaspar, involved-field radiotherapy, IFRT
Sun Yat-sen University, China Food and Drug Administration
Treatment Refusal
12/23
12/23
SPENT, NCT04676789: Anti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTL

Not yet recruiting
2
30
RoW
Pegaspargase, P-ASP, Anti-PD-1 monoclonal antibody, sintilimab, Definitive intensity-modulated radiotherapy (IMRT), IMRT
Sun Yat-sen University
Extranodal NK/T-cell Lymphoma, Nasal Type
09/24
12/24
NCT05564897: Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer

Recruiting
2
25
RoW
H101, Camrelizumab
Zhejiang Cancer Hospital
Bladder Cancer
09/24
12/24
TQB3702-II-02, NCT06566586: A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma

Recruiting
2
80
RoW
TQB3702 tablets+Chemotherapy regimen
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
B-cell Lymphoma
03/26
12/27
NCT02396043: Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

Recruiting
2
50
RoW
induction phase1, Vincristine,Pirarubicin,Prednisone,Pegaspargase, induction phase2, Cyclophosphamide,Cytarabine,Mercaptopurine, protocol M, Methotrexate,Mercaptopurine, maintenance therapy, 6-mercaptopurine,Methotrexate, reinduction phase1, reinduction phase2, Intrathecal (IT), methotrexate ,cytarabine and dexamethasone
Sun Yat-sen University
Lymphoma, Lymphoblastic
03/25
03/25
NCT03641456: VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma

Recruiting
2
50
RoW
bortezomib, Velcade, Lenalidomide, Revlimid, Dexamethasone, Dexamethasone Acetate
Sun Yat-sen University
Myeloma, Newly Diagnosed, High Risk
12/25
12/25
TranStar102, NCT04495296: A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors

Recruiting
1/2
320
RoW
TST001, Oxaliplatin, Capecitabine, Paclitaxel, Gemcitabine, Cisplatin, Nivolumab
Suzhou Transcenta Therapeutics Co., Ltd., Bristol-Myers Squibb
Advanced Cancer
02/25
05/25
NCT05824169: Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients

Recruiting
1/2
18
RoW
GC101
GeneCradle Inc
Spinal Muscular Atrophy
12/26
12/26
SHR-A1811-208, NCT06015048: A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors.

Recruiting
1/2
364
RoW
SHR-A1811 combined with Pyrotinib., SHR-A1811 combined with other antitumor therapies
Jiangsu HengRui Medicine Co., Ltd.
HER2-expressing Advanced Solid Tumors
11/26
12/26
NCT06525272: A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of OsrhCT in Patients With Pleurisy

Not yet recruiting
1
72
RoW
Recombinant Human Chymotrypsin(OsrhCT), Freeze-dried Powder of Recombinant Human Chymotrypsin(OsrhCT), Placebo for Recombinant Human Chymotrypsin(OsrhCT), Freeze-dried Powder of Placebo for Recombinant Human Chymotrypsin(OsrhCT)
Healthgen Biotechnology Corp.
Pleurisy
07/25
12/25
NCT02698839: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

Active, not recruiting
N/A
539
RoW
BuMA Supreme, BuMA™
Sino Medical Sciences Technology Inc.
Coronary Artery Disease
03/18
12/25
NCT04554511: Prognostic Nomogram of Extranodal NK/T-cell Lymphoma

Recruiting
N/A
1000
RoW
Sun Yat-sen University
Extranodal NK/T-cell Lymphoma
01/24
01/24
NCT03059043: Safety and Efficacy Study of A Viscoelastic-free Method for Implantable Collamer Lens (ICL) Implantation

Recruiting
N/A
60
RoW
viscoelastic-free implantation system, standard viscoelastic-assisted Implantation system
Wenzhou Medical University
Myopia
06/26
06/26
CAA+PGP#PWB, NCT06841133: Chinese Art Activities or Combined With Peer Group Participation on Psychological Well Being

Not yet recruiting
N/A
90
RoW
Chinese Art Activities, Chinese Art Activities combined with Peer Group Participation (PGP)
Prince of Songkla University
Aging
07/25
08/25
Jiang, Zongpei
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting
4
9000
RoW
Aspirin 100 mg Oral Tablet, Matching Placebo
Guangdong Provincial People's Hospital, The George Institute
CKD (Chronic Kidney Disease) Stage 5D
09/26
12/26
Xie, Jianteng
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting
4
9000
RoW
Aspirin 100 mg Oral Tablet, Matching Placebo
Guangdong Provincial People's Hospital, The George Institute
CKD (Chronic Kidney Disease) Stage 5D
09/26
12/26
Wen, Chaohui
NCT04381143: ASPIrin in Reducing Events in Dialysis ( ASPIRED )

Recruiting
4
9000
RoW
Aspirin 100 mg Oral Tablet, Matching Placebo
Guangdong Provincial People's Hospital, The George Institute
CKD (Chronic Kidney Disease) Stage 5D
09/26
12/26

Download Options